The clinical consequences of heterogeneity within and between different diabetes types
- 7 September 2020
- journal article
- review article
- Published by Springer Nature in Diabetologia
- Vol. 63 (10) , 2040-2048
Abstract
Advances in molecular methods and the ability to share large population-based datasets are uncovering heterogeneity within diabetes types, and some commonalities between types. Within type 1 diabetes, endotypes have been discovered based on demographic (e.g. age at diagnosis, race/ethnicity), genetic, immunological, histopathological, metabolic and/or clinical course characteristics, with implications for disease prediction, prevention, diagnosis and treatment. In type 2 diabetes, the relative contributions of insulin resistance and beta cell dysfunction are heterogeneous and relate to demographics, genetics and clinical characteristics, with substantial interaction from environmental exposures. Investigators have proposed approaches that vary from simple to complex in combining these data to identify type 2 diabetes clusters relevant to prognosis and treatment. Advances in pharmacogenetics and pharmacodynamics are also improving treatment. Monogenic diabetes is a prime example of how understanding heterogeneity within diabetes types can lead to precision medicine, since phenotype and treatment are affected by which gene is mutated. Heterogeneity also blurs the classic distinctions between diabetes types, and has led to the definition of additional categories, such as latent autoimmune diabetes in adults, type 1.5 diabetes and ketosis-prone diabetes. Furthermore, monogenic diabetes shares many features with type 1 and type 2 diabetes, which make diagnosis difficult. These challenges to the current classification framework in adult and paediatric diabetes require new approaches. The ‘palette model’ and the ‘threshold hypothesis’ can be combined to help explain the heterogeneity within and between diabetes types. Leveraging such approaches for therapeutic benefit will be an important next step for precision medicine in diabetes. Graphical abstractKeywords
This publication has 57 references indexed in Scilit:
- 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2020Diabetes Care, 2019
- Prospective virome analyses in young children at increased genetic risk for type 1 diabetesNature Medicine, 2019
- Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetesBMC Medicine, 2019
- Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress ReportDiabetes Care, 2019
- Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of HeterogeneityJournal of Diabetes Research, 2018
- The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease MechanismsCurrent Diabetes Reports, 2018
- A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at RiskDiabetes Care, 2018
- Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodiesJournal of Autoimmunity, 2018
- Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin DoseDiabetes Care, 2016
- Environmental risk factors for type 1 diabetesThe Lancet, 2016